• Latest Posts

Singapore’s biotech scene: six companies leading the way

Clearance for anti-tumor bispecific antibody trial

LabGenius looks to create molecules with huge increase in tumor killing ability

ADVERTISEMENT

FDA fast track for Memo’s kidney transplant infection treatment

Affibody and Chiesi Group to develop treatments for respiratory diseases

Antiverse identifies therapeutic antibodies targeting GPCRs

Hemab Therapeutics receives $135M to address bleeding and thrombotic disorders

FDA approves GSK drug for recurrent or advanced mismatch repair-deficient endometrial cancer

Antibody candidate for treating serious liver disease

ADVERTISEMENT